{"date":"2026-03-17","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6547-2026-03-17-1955-8u79u3","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"19:55:26","subject":"本公司恩穩健腸病毒71型疫苗通過越南新藥查驗登記核准，取得越南首張腸病毒疫苗藥證","clause":"第10款","fact_date":"2026-03-17","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-17 19:55，「本公司恩穩健腸病毒71型疫苗通過越南新藥查驗登記核准，取得越南首張腸病毒疫苗藥證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-03-17-1717-1t5gay1","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"17:17:52","subject":"本公司受邀參加櫃買中心舉辦之業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-03-17 17:17，「本公司受邀參加櫃買中心舉辦之業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-17-1645-8d6if0","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"16:45:27","subject":"本公司CatCHimera(凱玫樂)檢測平台，獲得美國食品藥物管理局（FDA）授予「突破性醫材認定」（Breakthrough Device Designation, BDD）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-17 16:45，「本公司CatCHimera(凱玫樂)檢測平台，獲得美國食品藥物管理局（FDA）授予「突破性醫材認定」（Breakthro」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-17-1644-qkrt5g","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"16:44:31","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-17 16:44，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-17-1644-1ol3y2x","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"16:44:07","subject":"公告本公司股票初次上市現金增資委託代收及存儲價款機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-17 16:44，「公告本公司股票初次上市現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-17-1641-1a5015l","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"16:41:34","subject":"發言人及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-17 16:41，「發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-17-1603-1e8f14h","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"16:03:10","subject":"代重要子公司UOC USA, Inc.公告股東常會董事改選當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-17 16:03，「代重要子公司UOC USA, Inc.公告股東常會董事改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-03-17-1602-nvqaze","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-03-17","time":"16:02:07","subject":"公告本公司與Zimvie TAIWAN CO.,LTD.(台灣捷威醫療器材有限公司)簽訂之人工頸椎間盤經銷合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-03-17 16:02，「公告本公司與Zimvie TAIWAN CO.,LTD.(台灣捷威醫療器材有限公司)簽訂之人工頸椎間盤經銷合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-17-1601-aspa9n","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"16:01:01","subject":"代重要子公司UOC USA, Inc.公告股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-17 16:01，「代重要子公司UOC USA, Inc.公告股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-17-1558-1ci5ryt","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"15:58:43","subject":"代重要子公司UOC USA, Inc.公告召開股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-17 15:58，「代重要子公司UOC USA, Inc.公告召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-17-1558-1vjs6sq","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"15:58:03","subject":"代重要子公司UOC USA, Inc.公告本公司董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-17 15:58，「代重要子公司UOC USA, Inc.公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-17-1551-p1eqv9","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"15:51:12","subject":"因本公司有價證券於集中市場達公布注意交易資訊標準故公布相關財務業務等重大訊息,以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-17 15:51，「因本公司有價證券於集中市場達公布注意交易資訊標準故公布相關財務業務等重大訊息,以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-17-1545-11qiaz3","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-17","time":"15:45:33","subject":"本公司董事會決議召開115年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-17 15:45，「本公司董事會決議召開115年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-17-1543-ag0ktz","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"15:43:59","subject":"本公司受邀參加永豐金證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-17 15:43，「本公司受邀參加永豐金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-17-1535-1eoxwr9","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-17","time":"15:35:00","subject":"本公司受邀參加宏遠證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-17 15:35，「本公司受邀參加宏遠證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-17-1527-nfgghf","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-17","time":"15:27:58","subject":"公告本公司產品「SIPSIP 傷口凝膠 (滅菌)」取得衛福部第一類醫療器材許可證","clause":"第44款","fact_date":"2026-03-17","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-17 15:27，「公告本公司產品「SIPSIP 傷口凝膠 (滅菌)」取得衛福部第一類醫療器材許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-17-1430-bjnnlu","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"14:30:23","subject":"公告本公司114年度個體及合併財務報告董事會預計召開日期為115年03月25日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-17 14:30，「公告本公司114年度個體及合併財務報告董事會預計召開日期為115年03月25日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-17-1346-xdqpty","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-17","time":"13:46:19","subject":"本公司接獲加拿大授權夥伴通知，白內障手術後炎症和疼痛治療新藥APP13007已獲加拿大衛生部核准上市","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-17 13:46，「本公司接獲加拿大授權夥伴通知，白內障手術後炎症和疼痛治療新藥APP13007已獲加拿大衛生部核准上市」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}